Northwest Biotherapeutics Innovations for Cancer
Home >> Investors & Media >> Press Releases

Press Releases

Media Contact:
Lorie Calvo
425-608-3008

Northwest Biotherapeutics, Inc.
("NWBT" or "the Company”)

Issue of Shares



Northwest Biotherapeutics, Inc. (AIM: NWBS and NWBT; OTC BB: NWBO.US), announces it has issued 335,097 shares of common stock $0.001 par value, representing 0.7913% of the issued share capital, in fulfillment of warrant exercises at a price of US$2.10 per share. The shares were issued as follows: 20,213 shares on 11 July 2007, 57,771 shares on 12 July 2007 and 257,113 shares on 16 July 2007.

Application has been made today for the shares to be admitted to trading on AIM on 6 November 2007.

For further information, please contact:

Northwest Biotherapeutics
Anthony P. Deasey, Chief Financial Officer

+ 1 240 497 9024
Buchanan Communications
Lisa Baderoon (lisab@buchanan.uk.com)
/ Mary-Jane Johnson / Catherine Breen

+44 (0)20 7466 5000
Collins Stewart
Tim Mickley / Adam Cowen

+44 (0)20 7523 8000